Clindamycin vs Tofacitinib

## Clindamycin vs Tofacitinib: Overview

This comparison examines the pharmacological differences between **Clindamycin** and **Tofacitinib**.

## Mechanism of Action

**Clindamycin**: Binds 50S ribosomal subunit inhibiting protein synthesis.

**Tofacitinib**: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

## Pharmacokinetics

**Half-life**: Clindamycin — 2-3 hours; Tofacitinib — 3.2 hours.

## Chemical Properties

**Molecular Formula**: Clindamycin — C18H33ClN2O5S; Tofacitinib — C16H20N6O.

**Molecular Weight**: Clindamycin — 424.9830 g/mol; Tofacitinib — 312.3700 g/mol.

**Type**: Clindamycin — Small molecule; Tofacitinib — Small molecule.